These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28744223)

  • 1. Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans.
    Motta G; Tersariol ILS
    Front Physiol; 2017; 8():481. PubMed ID: 28744223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin release avoids high molecular weight kininogen endocytosis.
    Damasceno IZ; Melo KR; Nascimento FD; Souza DS; Araujo MS; Souza SE; Sampaio MU; Nader HB; Tersariol IL; Motta G
    PLoS One; 2015; 10(3):e0121721. PubMed ID: 25822177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface.
    Veronez CL; Nascimento FD; Melo KR; Nader HB; Tersariol IL; Motta G
    PLoS One; 2014; 9(3):e91280. PubMed ID: 24621563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
    Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
    Front Immunol; 2018; 9():21. PubMed ID: 29467753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of heparan sulfate proteoglycans in cellular uptake of high molecular weight kininogen.
    Melo KR; Gutierrez A; Nascimento FD; Araújo MK; Sampaio MU; Carmona AK; Coulson-Thomas YM; Trindade ES; Nader HB; Tersariol IL; Motta G
    Biol Chem; 2009 Feb; 390(2):145-55. PubMed ID: 19040351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin.
    Etscheid M; Beer N; Fink E; Seitz R; Johannes D
    Biol Chem; 2002 Oct; 383(10):1633-43. PubMed ID: 12452440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein activates bradykinin B2 receptors in absence of kininogen.
    Biyashev D; Tan F; Chen Z; Zhang K; Deddish PA; Erdös EG; Hecquet C
    Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1244-50. PubMed ID: 16272198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta.
    Hermann A; Buchinger P; Somlev B; Rehbock J
    Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.
    Kenne E; Rasmuson J; Renné T; Vieira ML; Müller-Esterl W; Herwald H; Lindbom L
    FASEB J; 2019 Feb; 33(2):2599-2609. PubMed ID: 30281335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
    Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
    Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the plasma kallikrein/kinin system on endothelial cells.
    Rojkjaer R; Schmaier AH
    Proc Assoc Am Physicians; 1999; 111(3):220-7. PubMed ID: 10354362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
    Røjkjaer R; Schmaier AH
    Immunopharmacology; 1999 Sep; 43(2-3):109-14. PubMed ID: 10596841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase.
    Sato F; Nagasawa S
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1009-17. PubMed ID: 3228488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma contact activation: a revised hypothesis.
    Schmaier AH
    Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.